Verified Supplement Data Primary-sourced

How Long Does Citrus Bergamot Take to Work?

By Erin Rose · Published · Methodology · About Us

Informational summary of published clinical trial timelines — not medical advice. Citrus bergamot carries a real statin/CYP3A4 drug-interaction caution; talk to your clinician before combining it with a statin or other prescription medication.

Citrus bergamot's cholesterol trials ran anywhere from 30 days to 6 months. The earliest positive result was measured at 30 days. But no trial checked in before its own endpoint, so trial length isn't the same as how fast the effect actually appeared.

A 500mg/day dose failed at 60 days in one trial — a dose problem, not a timing one. Give it at least 30 days before expecting anything, and don't assume a longer wait guarantees a bigger result.

Know your dose already? See the best citrus bergamot picks, ranked by standardization and cost →

Timeline by Trial

Bergamot's cholesterol evidence comes from six trials at six different durations. Each one measured its result only at the end of the study — none report an earlier interim reading, so the duration column below is trial length, not proof of how soon the change happened.

Citrus bergamot trial durations and what was measured at each endpoint
Trial Dose Duration Result at That Endpoint
Gliozzi 2013 1,000mg/day BPF, added to rosuvastatin 30 days Enhanced the statin's LDL-lowering effect (open-label)
Bruno 2017 500mg/day BPF 60 days No effect (psychiatric outpatients on antipsychotics)
Pierdomenico 2023 400mg/day (Brumex™) 12 weeks Significant TC/TG/LDL/ApoB100 reduction, double-blind
Capomolla 2019 (650mg arm) 650mg/day (BPE-C) 90 days Improved atherogenic index, smaller effect than the high-dose arm
Capomolla 2019 (1,300mg arm) 1,300mg/day (BPE-C) 90 days Largest effect in this evidence pack: triglycerides −32%, glucose −18.1%
Toth 2015 150mg/day disclosed flavonoids (Bergavit®) 6 months LDL −19.6%; no placebo control, so diet or observer effects can't be ruled out

Sources: Gliozzi M, et al. Int J Cardiol. 2013. PMID 24239156; Bruno A, et al. Front Pharmacol. 2017. PMID 28443024; Pierdomenico M, et al. Phytother Res. 2023. PMID 37312672; Capomolla AS, et al. Nutrients. 2019. PMID 31167512; Toth PP, et al. Front Pharmacol. 2015/2016. PMID 26779019 — all cited on our dosage guide and for-cholesterol pages.

Trial Length Isn't Onset Speed

Every number in that table is an endpoint, not a growth curve. Gliozzi 2013 measured its result at 30 days — it didn't check at day 10 or day 20 along the way. Toth 2015 measured at 6 months, with no earlier reading at all.

So the honest read is: by day 30, one trial found a change. By 12 weeks, another did. By 6 months, a third did, in a study without a placebo arm to rule out other explanations. None of that tells you the shortest time in which bergamot could plausibly work — only the point at which each specific trial happened to look.

Why the 500mg Dose Failed at 60 Days

Bruno 2017 tested 500mg/day for 60 days and found no metabolic improvement. That's a similar duration to trials that did find a benefit at higher doses, so the honest explanation is the dose, not the clock. Don't read that null result as "bergamot needs more time" — read it as "500mg/day wasn't enough in that population."

The Standardization & Statin Caution Still Apply

Whatever timeline you're working with, two things from the rest of this evidence base still matter here. Only a standardized, polyphenol-disclosed product can be compared to what these trials actually tested — see our standardization ranking. And because bergamot shares grapefruit's CYP3A4 chemistry, talk to your doctor before combining it with a statin, regardless of how long you plan to take it.

What to Take During the Trial Window

Standardized Citrus Bergamot 150:1 Extract, 70% Polyphenols, Italian Sourced (1200mg) $0.37/day

A disclosed polyphenol percentage, at a dose inside the trial-tested range. Taking it doesn't shorten the 30-day-to-6-month window above — it just means you're taking a product that can actually be compared to the trials.

Check price →

When to Reassess

Give it at least 30 days — the earliest point any trial in this evidence pack found a change. Don't expect a verdict before then, and don't assume waiting longer than 90 days to 6 months guarantees a bigger result; that's simply where the longest trials happened to stop measuring.

If you're on a statin or any other CYP3A4-metabolized medication, that conversation with your doctor doesn't wait for a timeline — have it before you start.

Frequently Asked Questions

How long does citrus bergamot take to lower cholesterol?

The trials behind this evidence ran anywhere from 30 days to 6 months. The earliest positive result was measured at 30 days, in a trial adding bergamot to a statin. But no trial checked in earlier than its own endpoint, so we can't say how much of that 30 days it actually took to show up.

Does a higher dose of citrus bergamot work faster?

There's no timing data to answer that. One trial tested 650mg/day against 1,300mg/day over the same 90 days and found the higher dose produced a bigger effect at that same endpoint — not a faster one. Dose and speed are different questions, and only the first one has evidence behind it here.

Did the 500mg dose fail because it needed more time?

No — that reads as a dose issue, not a timing one. The trial that found no effect at 500mg/day ran 60 days, a similar length to trials that did find a benefit at higher doses. The problem wasn't that 60 days was too short; the dose itself may have been too low for that population.

Should I expect a change by 30 days?

Maybe, but hold it loosely. One trial found an enhanced cholesterol effect at 30 days when bergamot was added to a statin. That doesn't tell you whether the change happened on day 5 or day 29, and most of the other trials didn't measure anything before 60 days or later.

Related Guides

Sources

  1. Gliozzi M, et al. "Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDL-cholesterol." Int J Cardiol. 2013. PMID: 24239156
  2. Bruno A, Pandolfo G, Muscatello MRA, et al. "Low-Dose of Bergamot-Derived Polyphenolic Fraction (BPF) Did Not Improve Metabolic Parameters in Second Generation Antipsychotics-Treated Patients." Front Pharmacol. 2017. PMID: 28443024
  3. Pierdomenico M, Cicero AFG, Veronesi M, Fogacci F, et al. "Effect of Citrus bergamia extract on lipid profile: A combined in vitro and human study." Phytother Res. 2023. PMID: 37312672
  4. Capomolla AS, et al. "Atherogenic Index Reduction and Weight Loss in Metabolic Syndrome Patients Treated with A Novel Pectin-Enriched Formulation of Bergamot Polyphenols." Nutrients. 2019. PMID: 31167512
  5. Toth PP, et al. "Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study." Front Pharmacol. 2015 (pub. 2016). PMID: 26779019